Table 2.
Distribution of Jk antigen and phenotype frequencies in CKD patients and controls (total and >45 years old).
| CKD Patients n = 197 n (%) |
Control Total (n = 444) n (%) |
Control >45 years old (n = 94) n (%) |
|
|---|---|---|---|
| Phenotypes | |||
| Jk(a − b+) | 44 (22.3) | 121 (27.2)a | 29 (30.8)e |
| Jk(a + b−) | 60 (30.5) | 108 (24.3)b | 23 (24.5)f |
| Jk(a + b+) | 93 (47.2) | 215 (48.4)c | 42 (44.7)g |
| Jk antigens | |||
| Jka | 213 (54.0) | 431 (49.0)d | 90 (48.0)h |
| Jkb | 181 (46.0) | 457 (51.0) | 98 (52.0) |
ap-Value = 0.32; bp-Value = 0.55; cp-Value = 1; dp-Value = 0.16 (CKD patients vs. controls − total of samples).
ep-Value = 0.55; fp-Value = 0.18; gp-Value = 1; hp-Value = 0.16 (CKD patients vs. controls >45 years old).